Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
alzheimer's disease
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
2
×
deals
detroit blog main
detroit top stories
diagnostics
2
×
eli lilly
2
×
gilead sciences
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adalimumab (humira)
aducanumab
aduro biotech
What
bio
drug
roundup
acquisitions
approval
biggest
biogen’s
biopharmaceutical
build
buy
ceo
companies
company’s
convo
daniel
debut
dyne’s
earlier
failures
gilead
littered
microbiome
moves
nash
new
news
openly
o’day
pipeline
price
remains
road
sciences
scores
seagen
spoken
strategy
talk
way
week
Language
unset
Current search:
diagnostics
×
cancer
×
" eli lilly "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
